Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms PHOTAC-I-2 |
Target |
Action- |
Mechanism Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H45ClN10O8S |
InChIKeyTWLVSZYPENTZJC-HNKSWKDBSA-N |
CAS Registry- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 21 Feb 2020 | |
| Neoplasms | Preclinical | Germany | 21 Feb 2020 |





